ArticleCancer biology & medicine2020

Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways

Xiaoling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.